Cover Image
Market Research Report
Product code
977305

North America Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027

Published: | Data Bridge Market Research Private Limited | 100 Pages | Delivery time: 3-5 business days

Price

Back to Top
North America Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027
Published: October 1, 2020
Data Bridge Market Research Private Limited
Content info: 100 Pages
Delivery time: 3-5 business days
  • ALL
  • Description
  • Table of Contents
Description

North America alopecia treatment (hair loss) market is projected to register a CAGR of 5.4% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

North America Alopecia Treatment (Hair Loss) Market, By Disease Type (Non-Cicatricial Alopecia, Traction Alopecia, Ciatricial Alopecia, Others), Treatment (Localized Therapies, Medical Devices, Systemic Therapies, Herbal Treatment), Gender (Male, Female), Form (Topical, Oral, Parenteral), End User (Dermatology Centers, Hospitals, Home Healthcare), Distribution Channel (Pharmacies, Retail Sales, Direct Tender), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of North America alopecia treatment (hair loss) market are:

Technological advancements in hair treatment medical devices

Increase in prevalence of chemotherapy induced alopecia

Market Players:

The key market players for North America alopecia treatment (hair loss) market are listed below:

iGrow Laser

Lexington Intl., LLC.

Curallux, LLC.

HCell Inc.

Freedom Laser Therapy, Inc.

Taisho Pharmaceutical Holdings Co., Ltd.

Vita-Cos-Med Klett-Loch GmbH

WOCKHARDT

Teva Pharmaceuticals USA, Inc. (A Subsidiary of Teva Pharmaceuticals Industries Ltd.)

Pfizer Inc.

Par Pharmaceutical (A Subsidiary of Endo International plc)

GlaxoSmithKline plc

Dr. Reddy's Laboratories Ltd.

Abbott

Zydus Pharmaceuticals, Inc. (A subsidiary of Zydus Cadila)

Johnson & Johnson Services, Inc

Cipla Inc.

Sun Pharmaceutical Industries Ltd.

Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., Inc.

Aurobindo Pharma

Perrigo Company plc

Viviscal Limited (A Subsidiary of Church & Dwight Co.)

Dr. Kurt Wolff GmbH & Co. KG

Labo International S.r.l.

Watermans

WON TECH Co., Ltd.

PureTech

Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 DISEASE TYPE OF ALOPECIA TREATMENT (HAIR LOSS) LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET TREATMENT COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: REGULATIONS

5 EPIDERMOLOGY

6 PIPELINE ANALYSIS

7 IMPACT OF COVID 19 PANDEMIC ON THE MARKET

  • 7.1 PRICE IMPACT
  • 7.2 IMPACT ON SUPPLY CHAIN
  • 7.3 IMPACT ON DEMAND
  • 7.4 STRATEGIC DECISIONS FOR MANUFACTURERS
  • 7.5 CONCLUSION

8 MARKET OVERVIEW

  • 8.1 DRIVERS
    • 8.1.1 INCREASE IN GERIATRIC POPULATION
    • 8.1.2 RISE IN PREVALENCE OF ALOPECIA CONDITIONS
    • 8.1.3 INCREASE IN PREVALENCE OF CHEMOTHERAPY INDUCED ALOPECIA
    • 8.1.4 INCREASING LEVEL OF STRESS
    • 8.1.5 CHANGING LIFESTYLES
  • 8.2 RESTRAINTS
    • 8.2.1 SIDE EFFECTS ASSOCIATED WITH THE AVAILABLE HAIR LOSS TREATMENT THERAPIES
    • 8.2.2 HIGH COST OF THERAPIES
    • 8.2.3 RECALL OF DRUG
  • 8.3 OPPORTUNITIES
    • 8.3.1 TECHNOLOGICAL ADVANCEMENTS IN HAIR TREATMENT MEDICAL DEVICES
    • 8.3.2 RISING DISPOSABLE INCOME
    • 8.3.3 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
    • 8.3.4 INCREASING AWARENESS REGARDING THE ALOPECIA (HAIR LOSS)
  • 8.4 CHALLENGES
    • 8.4.1 PATENT EXPIRATION
    • 8.4.2 IMPROPER REIMBURSEMENT POLICIES
    • 8.4.3 EXISTENCE OF ALTERNATIVE TREATMENT OPTIONS

9 NORTH AMERICA ALOPECIATREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE

  • 9.1 OVERVIEW
  • 9.2 NON-CICATRICIAL ALOPECIA
    • 9.2.1 ANDROGENIC ALOPECIA
    • 9.2.2 ALOPECIA AREATA
    • 9.2.3 ALOPECIA UNIVERSALIS
    • 9.2.4 ANAGEN ARREST/ANAGEN EFFLUVIUM
    • 9.2.5 TELOGEN EFFLUVIUM
  • 9.3 TRACTION ALOPECIA
  • 9.4 CIATRICIAL ALOPECIA
    • 9.4.1 FRONTAL FIBROSING ALOPECIA
    • 9.4.2 FOLLICULITIS DECALVANS
    • 9.4.3 LICHEN PLANOPILARIS
  • 9.5 OTHERS

10 NORTH AMERICA ALOPECIATREATMENT (HAIR LOSS) MARKET, BY TREATMENT

  • 10.1 OVERVIEW
  • 10.2 LOCALIZED THERAPIES
    • 10.2.1 MINOXIDIL
    • 10.2.2 INTRALESIONAL CORTICOSTEROIDS
    • 10.2.3 TRIAMCINOLONE ACETONIDE
    • 10.2.4 HYDROCORTISONE ACETATE
    • 10.2.5 OTHERS
    • 10.2.6 TOPICAL CORTICOSTEROIDS
      • 10.2.6.1 Clobetasol Propionate
      • 10.2.6.2 Betamethasone Valerate
      • 10.2.6.3 Fluocinolone
      • 10.2.6.4 Dexamethasone
      • 10.2.6.5 Halcinonide
    • 10.2.7 FINASTERIDE
    • 10.2.8 ANTHRALIN
    • 10.2.9 TOPICAL IMMUNOTHERAPY
    • 10.2.10 MICRONUTRIENT SUPPLEMENTATION
      • 10.2.10.1 Vitamin A
      • 10.2.10.2 Vitamin D
      • 10.2.10.3 Iron
      • 10.2.10.4 Zinc
      • 10.2.10.5 Niacin
      • 10.2.10.6 Folic Acid
      • 10.2.10.7 Others
    • 10.2.11 OTHERS
  • 10.3 MEDICAL DEVICES
    • 10.3.1 LASER TREATMENT
      • 10.3.1.1 Hair Comb
      • 10.3.1.2 Wearable Laser Devices
      • 10.3.1.3 Cap
      • 10.3.1.4 Hair Band
      • 10.3.1.5 Helmet
      • 10.3.1.6 Machines
    • 10.3.2 HIGH POWER LED
    • 10.3.3 PHOTOTHERAPY
      • 10.3.3.1 Ultraviolet A-1
      • 10.3.3.2 Narrowband Ultraviolet B
  • 10.4 SYSTEMIC THERAPIES
    • 10.4.1 CORTICOSTEROIDS
    • 10.4.2 METHOTREXATE
    • 10.4.3 CYCLOSPORINE
    • 10.4.4 OTHERS
  • 10.5 HERBAL TREATMENT
    • 10.5.1 ALOE BARBADENSIS
    • 10.5.2 PHYLLANTHUS EMBELICA
    • 10.5.3 PRUNUS AMYGDALUS
    • 10.5.4 AVENA SATIVA
    • 10.5.5 AMARANTHUS SPINOSUS
    • 10.5.6 CAJANUS CAJAN
    • 10.5.7 DAUCUS CAROTA
    • 10.5.8 JUGLANS REGIA
    • 10.5.9 BACOPA MONNIERE
    • 10.5.10 MEDICAGO SATIVA
    • 10.5.11 LACTUCA SATIVA
    • 10.5.12 PELVETIA CANALICULATA
    • 10.5.13 OTHERS

11 NORTH AMERICA ALOPECIATREATMENT (HAIR LOSS) MARKET, BY GENDER

  • 11.1 OVERVIEW
  • 11.2 MALE
  • 11.3 FEMALE

12 NORTH AMERICA ALOPECIATREATMENT (HAIR LOSS) MARKET, BY FORM

  • 12.1 OVERVIEW
  • 12.2 TOPICAL
    • 12.2.1 CREAM
    • 12.2.2 SOLUTION
    • 12.2.3 OTHERS
  • 12.3 ORAL
    • 12.3.1 TABLET
    • 12.3.2 CAPSULES
    • 12.3.3 OTHERS
  • 12.4 PARENTERAL
    • 12.4.1 INTRAVENOUS
    • 12.4.2 INTRAMUSCULAR

13 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER

  • 13.1 OVERVIEW
  • 13.2 DERMATOLOGY CENTERS
  • 13.3 HOSPITALS
  • 13.4 HOME HEALTHCARE

14 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL

  • 14.1 OVERVIEW
  • 14.2 PHARMACIES
    • 14.2.1 OSPITAL
    • 14.2.2 RETAIL
    • 14.2.3 ONLINE
  • 14.3 RETAIL SALES
  • 14.4 DIRECT TENDER

15 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GEOGRAPHY

  • 15.1 NORTH AMERICA
    • 15.1.1 U.S.
    • 15.1.2 CANADA
    • 15.1.3 MEXICO

16 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, COMPANY LANDSCAPE

  • 16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

17 SWOT

18 COMPANY PROFILES

  • 18.1 JOHNSON & JOHNSON SERVICES, INC
    • 18.1.1 COMPANY SNAPSHOT
    • 18.1.2 REVENUE ANALYSIS
    • 18.1.3 COMPANY SHARE ANALYSIS
    • 18.1.4 PRODUCT PORTFOLIO
    • 18.1.5 RECENT DEVELOPMENTS
  • 18.2 GLAXOSMITHKLINE PLC
    • 18.2.1 COMPANY SNAPSHOT
    • 18.2.2 REVENUE ANALYSIS
    • 18.2.3 COMPANY SHARE ANALYSIS
    • 18.2.4 PRODUCT PORTFOLIO
    • 18.2.5 RECENT DEVELOPMENTS
  • 18.3 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
    • 18.3.1 COMPANY SNAPSHOT
    • 18.3.2 REVENUE ANALYSIS
    • 18.3.3 COMPANY SHARE ANALYSIS
    • 18.3.4 PRODUCT PORTFOLIO
    • 18.3.5 RECENT DEVELOPMENTS
  • 18.4 MERCK SHARP & DOHME CORP. (A SUBSIDIARY OF MERCK & CO., INC.)
    • 18.4.1 COMPANY SNAPSHOT
    • 18.4.2 REVENUE ANALYSIS
    • 18.4.3 COMPANY SHARE ANALYSIS
    • 18.4.4 PRODUCT PORTFOLIO
    • 18.4.5 RECENT DEVELOPMENT
  • 18.5 SUN PHARMACEUTICAL INDUSTRIES LTD.
    • 18.5.1 COMPANY SNAPSHOT
    • 18.5.2 REVENUE ANALYSIS
    • 18.5.3 PRODUCT PORTFOLIO
    • 18.5.4 RECENT DEVELOPMENTS
  • 18.6 PFIZER INC.
    • 18.6.1 COMPANY SNAPSHOT
    • 18.6.2 REVENUE ANALYSIS
    • 18.6.3 PRODUCT PORTFOLIO
    • 18.6.4 RECENT DEVELOPMENTS
  • 18.7 ZYDUS PHARMACEUTICALS, INC. (A SUBSIDIARY OF ZYDUS CADILA)
    • 18.7.1 COMPANY SNAPSHOT
    • 18.7.2 REVENUE ANALYSIS
    • 18.7.3 PRODUCT PORTFOLIO
    • 18.7.4 RECENT DEVELOPMENTS
  • 18.8 PAR PHARMACEUTICAL (A SUBSIDIARY OF ENDO INTERNATIONAL PLC)
    • 18.8.1 COMPANY SNAPSHOT
    • 18.8.2 REVENUE ANALYSIS
    • 18.8.3 PRODUCT PORTFOLIO
    • 18.8.4 RECENT DEVELOPMENTS
  • 18.9 TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICALS INDUSTRIES LTD.)
    • 18.9.1 COMPANY SNAPSHOT
    • 18.9.2 REVENUE ANALYSIS
    • 18.9.3 PRODUCT PORTFOLIO
    • 18.9.4 RECENT DEVELOPMENTS
  • 18.10 CIPLA INC.
    • 18.10.1 COMPANY SNAPSHOT
    • 18.10.2 REVENUE ANALYSIS
    • 18.10.3 PRODUCT PORTFOLIO
    • 18.10.4 RECENT DEVELOPMENTS
  • 18.11 ALES GROUPE
    • 18.11.1 COMPANY SNAPSHOT
    • 18.11.2 PRODUCT PORTFOLIO
    • 18.11.3 RECENT DEVELOPMENTS
  • 18.12 AUROBINDO PHARMA
    • 18.12.1 COMPANY SNAPSHOT
    • 18.12.2 REVENUE ANALYSIS
    • 18.12.3 PRODUCT PORTFOLIO
    • 18.12.4 RECENT DEVELOPMENTS
  • 18.13 ABBOTT
    • 18.13.1 COMPANY SNAPSHOT
    • 18.13.2 REVENUE ANALYSIS
    • 18.13.3 PRODUCT PORTFOLIO
    • 18.13.4 RECENT DEVELOPMENTS
  • 18.14 CURALLUX, LLC.
    • 18.14.1 COMPANY SNAPSHOT
    • 18.14.2 PRODUCT PORTFOLIO
    • 18.14.3 RECENT DEVELOPMENTS
  • 18.15 DR. KURT WOLFF GMBH & CO. KG
    • 18.15.1 COMPANY SNAPSHOT
    • 18.15.2 BRAND PORTFOLIO
    • 18.15.3 RECENT DEVELOPMENTS
  • 18.16 DR. REDDY'S LABORATORIES LTD.
    • 18.16.1 COMPANY SNAPSHOT
    • 18.16.2 REVENUE ANALYSIS
    • 18.16.3 PRODUCT PORTFOLIO
    • 18.16.4 RECENT DEVELOPMENTS
  • 18.17 FREEDOM LASER THERAPY, INC.
    • 18.17.1 COMPANY SNAPSHOT
    • 18.17.2 PRODUCT PORTFOLIO
    • 18.17.3 RECENT DEVELOPMENTS
  • 18.18 FOLLICUM AB
    • 18.18.1 COMPANY SNAPSHOT
    • 18.18.2 PRODUCT PORTFOLIO
    • 18.18.3 RECENT DEVELOPMENTS
  • 18.19 GEROLYMATOS INTERNATIONAL SA
    • 18.19.1 COMPANY SNAPSHOT
    • 18.19.2 PRODUCT PORTFOLIO
    • 18.19.3 RECENT DEVELOPMENTS
  • 18.20 HCELL INC.
    • 18.20.1 COMPANY SNAPSHOT
    • 18.20.2 PRODUCT PORTFOLIO
    • 18.20.3 RECENT DEVELOPMENT
  • 18.21 IGROW LASER
    • 18.21.1 COMPANY SNAPSHOT
    • 18.21.2 PRODUCT PORTFOLIO
    • 18.21.3 RECENT DEVELOPMENTS
  • 18.22 LABO INTERNATIONAL S.R.L.
    • 18.22.1 COMPANY SNAPSHOT
    • 18.22.2 PRODUCT PORTFOLIO
    • 18.22.3 RECENT DEVELOPMENT
  • 18.23 LEXINGTON INTL., LLC.
    • 18.23.1 COMPANY SNAPSHOT
    • 18.23.2 PRODUCT PORTFOLIO
    • 18.23.3 RECENT DEVELOPMENTS
  • 18.24 NANOGEN
    • 18.24.1 COMPANY SNAPSHOT
    • 18.24.2 PRODUCT PORTFOLIO
    • 18.24.3 RECENT DEVELOPMENTS
  • 18.25 PERRIGO COMPANY PLC
    • 18.25.1 COMPANY SNAPSHOT
    • 18.25.2 REVENUE ANALYSIS
    • 18.25.3 PRODUCT PORTFOLIO
    • 18.25.4 RECENT DEVELOPMENTS
  • 18.26 PURETECH
    • 18.26.1 COMPANY SNAPSHOT
    • 18.26.2 REVENUE ANALYSIS
    • 18.26.3 PRODUCT PORTFOLIO
    • 18.26.4 RECENT DEVELOPMENTS
  • 18.27 VITABIOTICS LTD.
    • 18.27.1 COMPANY SNAPSHOT
    • 18.27.2 PRODUCT PORTFOLIO
    • 18.27.3 RECENT DEVELOPMENTS
  • 18.28 VITA-COS-MED KLETT-LOCH GMBH
    • 18.28.1 COMPANY SNAPSHOT
    • 18.28.2 PRODUCT PORTFOLIO
    • 18.28.3 RECENT DEVELOPMENT
  • 18.29 VIVISCAL LIMITED (A SUBSIDIARY OF CHURCH & DWIGHT CO.)
    • 18.29.1 COMPANY SNAPSHOT
    • 18.29.2 REVENUE ANALYSIS
    • 18.29.3 PRODUCT PORTFOLIO
    • 18.29.4 RECENT DEVELOPMENT
  • 18.30 WATERMANS
    • 18.30.1 COMPANY SNAPSHOT
    • 18.30.2 PRODUCT PORTFOLIO
    • 18.30.3 RECENT DEVELOPMENT
  • 18.31 WOCKHARDT
    • 18.31.1 COMPANY SNAPSHOT
    • 18.31.2 REVENUE ANALYSIS
    • 18.31.3 PRODUCT PORTFOLIO
    • 18.31.4 RECENT DEVELOPMENTS
  • 18.32 WON TECH CO., LTD.
    • 18.32.1 COMPANY SNAPSHOT
    • 18.32.2 PRODUCT PORTFOLIO
    • 18.32.3 RECENT DEVELOPMENTS

19 QUESTIONNAIRE

20 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, PIPELINE ANALYSIS
  • TABLE 2 INCIDENCE OF ALOPECIA ASSOCIATED TO THE MAIN CHEMOTHERAPIC DRUG CATEGORIES
  • TABLE 3 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
  • TABLE 4 NORTH AMERICA NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 5 NORTH AMERICA NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 6 NORTH AMERICA TRACTION ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 7 NORTH AMERICA CIATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 8 NORTH AMERICA CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 9 NORTH AMERICA OTHERS IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 10 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 11 NORTH AMERICA LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 12 NORTH AMERICA LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 13 NORTH AMERICA INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 14 NORTH AMERICA TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 15 NORTH AMERICA MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 16 NORTH AMERICA MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 17 NORTH AMERICA MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 18 NORTH AMERICA LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 19 NORTH AMERICA WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 20 NORTH AMERICA PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 21 NORTH AMERICA SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 22 NORTH AMERICA SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 23 NORTH AMERICA HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 24 NORTH AMERICA HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 25 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER, 2018-2027 (USD MILLION)
  • TABLE 26 NORTH AMERICA MALE IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 27 NORTH AMERICA FEMALE IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 28 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 29 NORTH AMERICA TOPICAL IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 30 NORTH AMERICA TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 31 NORTH AMERICA ORAL IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 32 NORTH AMERICA ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 33 NORTH AMERICA PARENTERAL IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 34 NORTH AMERICA PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 35 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 36 NORTH AMERICA DERMATOLOGY CENTERS IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 37 NORTH AMERICA HOSPITALS IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 38 NORTH AMERICA HOME HEALTHCARE IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 39 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 40 NORTH AMERICA PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 41 NORTH AMERICA PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 42 NORTH AMERICA RETAIL SALES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 43 NORTH AMERICA DIRECT TENDER IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 44 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 45 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 46 NORTH AMERICA NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 47 NORTH AMERICA CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 48 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 49 NORTH AMERICA LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 50 NORTH AMERICA INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 51 NORTH AMERICA TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 52 NORTH AMERICA MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 53 NORTH AMERICA MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 54 NORTH AMERICA LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 55 NORTH AMERICA WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 56 NORTH AMERICA PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 57 NORTH AMERICA SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 58 NORTH AMERICA HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 59 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 60 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 61 NORTH AMERICA TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 62 NORTH AMERICA ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 63 NORTH AMERICA PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 64 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 65 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 66 NORTH AMERICA PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 67 U.S. ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 68 U.S. NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 69 U.S. CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 70 U.S. ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 71 U.S. LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 72 U.S. INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 73 U.S. TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 74 U.S. MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 75 U.S. MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 76 .S. LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 77 U.S. WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 78 U.S. PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 79 U.S. SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 80 U.S. HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 81 U.S. ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 82 U.S. ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 83 U.S. TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 84 U.S. ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 85 U.S. PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 86 U.S. ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 87 U.S. ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 88 U.S. PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 89 CANADA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 90 CANADA NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 91 CANADA CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 92 CANADA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 93 CANADA LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 94 CANADA INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 95 ANADA TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 96 CANADA MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 97 CANADA MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 98 CANADA LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 99 CANADA WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 100 CANADA PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 101 CANADA SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 102 CANADA HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 103 CANADA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 104 CANADA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 105 CANADA TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 106 CANADA ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 107 CANADA PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 108 CANADA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 109 CANADA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 110 CANADA PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 111 MEXICO ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 112 MEXICO NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 113 MEXICO CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 114 MEXICO ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 115 MEXICO LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 116 MEXICO INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 117 MEXICO TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 118 MEXICO MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 119 MEXICO MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 120 MEXICO LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 121 MEXICO WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 122 MEXICO PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 123 MEXICO SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 124 MEXICO HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 125 MEXICO ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 126 MEXICO ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 127 MEXICO TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 128 MEXICO ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 129 MEXICO PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 130 MEXICO ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 131 MEXICO ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 132 MEXICO PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: SEGMENTATION
  • FIGURE 2 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: SEGMENTATION
  • FIGURE 3 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: DROC ANALYSIS
  • FIGURE 4 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: MULTIVARIATE MODELLING
  • FIGURE 7 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 8 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: DBMR MARKET POSITION GRID
  • FIGURE 9 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: MARKET TREATMENT COVERAGE GRID
  • FIGURE 10 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 11 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: SEGMENTATION
  • FIGURE 12 INCREASE IN GERIATRIC POPULATION AND RISE IN PREVALENCE OF ALOPECIA CONDITIONS IS DRIVING THE NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 13 NON-CICATRICIAL ALOPECIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET IN 2020 & 2027
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET
  • FIGURE 15 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR ALOPECIA TREATMENT (HAIR LOSS) MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 16 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISEASE TYPE, 2019
  • FIGURE 17 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISEASE TYPE, 2019-2027 (USD MILLION)
  • FIGURE 18 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISEASE TYPE, CAGR (2020-2027)
  • FIGURE 19 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISEASE TYPE, LIFELINE CURVE
  • FIGURE 20 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TREATMENT, 2019
  • FIGURE 21 LOBAL ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TREATMENT, 2019-2027 (USD MILLION)
  • FIGURE 22 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TREATMENT, CAGR (2020-2027)
  • FIGURE 23 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TREATMENT, LIFELINE CURVE
  • FIGURE 24 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY GENDER, 2019
  • FIGURE 25 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY GENDER, 2019-2027 (USD MILLION)
  • FIGURE 26 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY GENDER, CAGR (2020-2027)
  • FIGURE 27 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY GENDER, LIFELINE CURVE
  • FIGURE 28 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY FORM, 2019
  • FIGURE 29 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY FORM, 2019-2027 (USD MILLION)
  • FIGURE 30 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY FORM, CAGR (2020-2027)
  • FIGURE 31 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY FORM, LIFELINE CURVE
  • FIGURE 32 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY END USER, 2019
  • FIGURE 33 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY END USER, 2019-2027 (USD MILLION)
  • FIGURE 34 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY END USER, CAGR (2020-2027)
  • FIGURE 35 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 36 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISTRIBUTION CHANNEL, 2019
  • FIGURE 37 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
  • FIGURE 38 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027)
  • FIGURE 39 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 40 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: SNAPSHOT (2019)
  • FIGURE 41 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY COUNTRY (2019)
  • FIGURE 42 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 43 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 44 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TYPE (2020-2027)
  • FIGURE 45 NORTH AMERICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: COMPANY SHARE 2019 (%)